Bio Rad Laboratories Inc (NYSE:BIO)

683.07
Delayed Data
As of Jul 23
 +7.66 / +1.13%
Today’s Change
472.84
Today|||52-Week Range
689.00
+17.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$16.9B

Company Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Contact Information

Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules California 94547
P:(510) 724-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders42.19%
Other institutional37.37%
Individual stakeholders26.31%

Top Executives

Norman D. SchwartzChairman, President & Chief Executive Officer
Andrew J. LastChief Operating Officer & Executive Vice President
Ilan DaskalChief Financial Officer & Executive Vice President
Timothy S. ErnstSecretary, Executive VP & General Counsel
Dara Grantham WrightEVP & President-Clinical Diagnostics Group